Status:
COMPLETED
An Observational Study of Japanese Participants With X-linked Retinitis Pigmentosa
Lead Sponsor:
Janssen Pharmaceutical K.K.
Conditions:
X-Linked Retinitis Pigmentosa
Eligibility:
All Genders
5+ years
Brief Summary
The purpose of the study is to identify a cohort of Japanese participants with X-linked retinitis pigmentosa (XLRP) associated with pathogenic variants in the retinitis pigmentosa GTPase regulator (RP...
Eligibility Criteria
Inclusion
- Have RPGR-associated retinal dystrophy
- Are able to give informed consent or assent, with the guidance of their parent/guardian where appropriate
- Are able to undertake age-appropriate clinical assessments as specified in the protocol
Exclusion
- Are unable or unwilling to undertake consent or clinical testing
- Participated in another research study and had intraocular surgery within 3 months of screening
- Significant ophthalmologic diseases
Key Trial Info
Start Date :
July 26 2021
Trial Type :
OBSERVATIONAL
Allocation :
ACTUAL
End Date :
April 23 2024
Estimated Enrollment :
15 Patients enrolled
Trial Details
Trial ID
NCT04868916
Start Date
July 26 2021
End Date
April 23 2024
Last Update
April 25 2025
Active Locations (1)
Enter a location and click search to find clinical trials sorted by distance.
1
National Hospital Organization Tokyo Medical Center
Tokyo, Japan, 152 8902